Dr. Hoang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
277 Park Ave, Fl 15
New York, NY 10172
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2016
Jefferson College of Biomedical Sciences, Thomas Jefferson UniversityPhD, Molecular Pharmacology and Structural Biology, 2010 - 2014- Drexel UniversityBS, Biological Sciences, 2004 - 2008
Awards, Honors, & Recognition
- MD/PhD Thesis Prize for Innovations in Translational Research Thomas Jefferson University, 2016
- NIH NRSA F31 Fellowship NIH, 2013-2016
Publications & Presentations
PubMed
- 17 citationsEnzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.Vindhya Udhane, Cristina Maranto, David T. Hoang, Lei Gu, Andrew Erickson
Molecular Cancer Therapeutics. 2020-01-01 - 41 citationsSTAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA RepairCristina Maranto, Vindhya Udhane, David T. Hoang, Lei Gu, Vitali Alexeev
Clinical Cancer Research. 2018-04-15 - 89 citationsAndrogen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple anglesDavid T. Hoang, Kenneth A. Iczkowski, Deepak Kilari, William A. See, Marja T. Nevalainen
Oncotarget. 2017-01-10
Grant Support
- Stat5 acts independently of androgen receptor to drive advanced prostate cancerNIH2013–2016
External Links
- LinkedInhttps://www.linkedin.com/in/davidtimothyhoang
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
